Ann Apolloni

2.4k total citations
24 papers, 2.0k citations indexed

About

Ann Apolloni is a scholar working on Molecular Biology, Virology and Oncology. According to data from OpenAlex, Ann Apolloni has authored 24 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Virology and 7 papers in Oncology. Recurrent topics in Ann Apolloni's work include HIV Research and Treatment (10 papers), Viral-associated cancers and disorders (7 papers) and Protein Kinase Regulation and GTPase Signaling (4 papers). Ann Apolloni is often cited by papers focused on HIV Research and Treatment (10 papers), Viral-associated cancers and disorders (7 papers) and Protein Kinase Regulation and GTPase Signaling (4 papers). Ann Apolloni collaborates with scholars based in Australia, United States and China. Ann Apolloni's co-authors include John F. Hancock, Sandrine Roy, Robert G. Parton, Jun Yan, Annette Lane, Ian A. Prior, Margaret Lindsay, T B Sculley, Espen Stang and Barbara J. Rolls and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Blood.

In The Last Decade

Ann Apolloni

24 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ann Apolloni Australia 18 1.3k 553 551 233 222 24 2.0k
Peter R. Strack United States 20 2.1k 1.6× 808 1.5× 255 0.5× 87 0.4× 116 0.5× 34 2.8k
Rachel Bagni United States 18 773 0.6× 616 1.1× 132 0.2× 163 0.7× 142 0.6× 30 1.4k
Daniel Cimbora United States 21 1.4k 1.1× 99 0.2× 421 0.8× 132 0.6× 236 1.1× 36 2.2k
Ivan Mikaélian France 22 1.2k 0.9× 378 0.7× 107 0.2× 117 0.5× 126 0.6× 42 1.7k
Tokameh Mahmoudi Netherlands 27 2.4k 1.8× 339 0.6× 191 0.3× 393 1.7× 141 0.6× 56 3.2k
Daitoku Sakamuro United States 24 1.5k 1.1× 822 1.5× 312 0.6× 68 0.3× 125 0.6× 39 2.4k
Gregor Cicchetti United States 10 974 0.7× 159 0.3× 337 0.6× 59 0.3× 62 0.3× 10 1.5k
Helen Yu United States 19 1.3k 0.9× 297 0.5× 297 0.5× 268 1.2× 29 0.1× 26 2.0k
James W. Peacock Canada 24 931 0.7× 525 0.9× 141 0.3× 70 0.3× 61 0.3× 41 1.6k
John Maciejowski United States 21 1.9k 1.4× 350 0.6× 684 1.2× 77 0.3× 58 0.3× 37 2.5k

Countries citing papers authored by Ann Apolloni

Since Specialization
Citations

This map shows the geographic impact of Ann Apolloni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann Apolloni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann Apolloni more than expected).

Fields of papers citing papers by Ann Apolloni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ann Apolloni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann Apolloni. The network helps show where Ann Apolloni may publish in the future.

Co-authorship network of co-authors of Ann Apolloni

This figure shows the co-authorship network connecting the top 25 collaborators of Ann Apolloni. A scholar is included among the top collaborators of Ann Apolloni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ann Apolloni. Ann Apolloni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lin, Min‐Hsuan, Ann Apolloni, Haran Sivakumaran, et al.. (2015). A Mutant Tat Protein Inhibits HIV-1 Reverse Transcription by Targeting the Reverse Transcription Complex. Journal of Virology. 89(9). 4827–4836. 17 indexed citations
2.
Apolloni, Ann, Min‐Hsuan Lin, Haran Sivakumaran, et al.. (2013). A Mutant Tat Protein Provides Strong Protection from HIV-1 Infection in Human CD4 + T Cells. Human Gene Therapy. 24(3). 270–282. 18 indexed citations
3.
Sivakumaran, Haran, Min‐Hsuan Lin, Ann Apolloni, et al.. (2013). Overexpression of PRMT6 does not suppress HIV-1 Tat transactivation in cells naturally lacking PRMT6. Virology Journal. 10(1). 207–207. 11 indexed citations
4.
Lin, Min‐Hsuan, Haran Sivakumaran, Ann Apolloni, et al.. (2012). Nullbasic, a Potent Anti-HIV Tat Mutant, Induces CRM1-Dependent Disruption of HIV Rev Trafficking. PLoS ONE. 7(12). e51466–e51466. 23 indexed citations
5.
Wei, Ting, Dongsheng Li, David Warrilow, et al.. (2012). Eukaryotic elongation factor 1 complex subunits are critical HIV-1 reverse transcription cofactors. Proceedings of the National Academy of Sciences. 109(24). 9587–9592. 49 indexed citations
6.
Sivakumaran, Haran, Armando van der Horst, Alex J. Fulcher, et al.. (2009). Arginine Methylation Increases the Stability of Human Immunodeficiency Virus Type 1 Tat. Journal of Virology. 83(22). 11694–11703. 45 indexed citations
7.
Apolloni, Ann, Luke W. Meredith, Andreas Suhrbier, Rosemary Kiernan, & David Harrich. (2007). The HIV-1 Tat Protein Stimulates Reverse Transcription In Vitro. Current HIV Research. 5(5). 474–483. 28 indexed citations
8.
Bodetti, Tracey, et al.. (2006). Protein methylation is required to maintain optimal HIV-1 infectivity. Retrovirology. 3(1). 92–92. 30 indexed citations
9.
Harrich, David, Nigel A.J. McMillan, Liliana Endo‐Munoz, Ann Apolloni, & Luke W. Meredith. (2006). Will Diverse Tat Interactions Lead to Novel Antiretroviral Drug Targets?. Current Drug Targets. 7(12). 1595–1606. 14 indexed citations
10.
Hooker, C. William, et al.. (2002). Human Immunodeficiency Virus Type 1 Reverse Transcription Is Stimulated by Tat from Other Lentiviruses. Virology. 300(2). 226–235. 9 indexed citations
11.
Clyde-Smith, Jodi, Michael G. Gartside, Sean M. Grimmond, et al.. (2000). Characterization of RasGRP2, a Plasma Membrane-targeted, Dual Specificity Ras/Rap Exchange Factor. Journal of Biological Chemistry. 275(41). 32260–32267. 113 indexed citations
12.
Apolloni, Ann, Ian A. Prior, Margaret Lindsay, Robert G. Parton, & John F. Hancock. (2000). H-ras but Not K-ras Traffics to the Plasma Membrane through the Exocytic Pathway. Molecular and Cellular Biology. 20(7). 2475–2487. 353 indexed citations
13.
Roy, Sandrine, Robert Luetterforst, Angus Harding, et al.. (1999). Dominant-negative caveolin inhibits H-Ras function by disrupting cholesterol-rich plasma membrane domains. Nature Cell Biology. 1(2). 98–105. 405 indexed citations
14.
Roy, Sandrine, R. A. McPherson, Ann Apolloni, et al.. (1998). 14-3-3 Facilitates Ras-Dependent Raf-1 Activation In Vitro and In Vivo. Molecular and Cellular Biology. 18(7). 3947–3955. 118 indexed citations
15.
Yan, Jun, Sandrine Roy, Ann Apolloni, Annette Lane, & John F. Hancock. (1998). Ras Isoforms Vary in Their Ability to Activate Raf-1 and Phosphoinositide 3-Kinase. Journal of Biological Chemistry. 273(37). 24052–24056. 390 indexed citations
16.
Apolloni, Ann & T B Sculley. (1994). Detection of A-Type and B-Type Epstein-Bart Virus in Throat Washings and Lymphocytes. Virology. 202(2). 978–981. 48 indexed citations
17.
Apolloni, Ann, Denis J. Moss, Scott R. Burrows, et al.. (1992). Sequence variation of cytotoxic T cell epitopes in different isolates of Epstein‐Barr virus. European Journal of Immunology. 22(1). 183–189. 36 indexed citations
18.
Moss, Denis J., I S Misko, T B Sculley, et al.. (1991). Immune regulation of Epstein-Barr virus (EBV): EBV nuclear antigen as a target for EBV-specific T cell lysis. Springer Seminars in Immunopathology. 13(2). 147–156. 8 indexed citations
19.
Sculley, T B, et al.. (1990). Coinfection with A and B-Type Epstein-Barr Virus in Human Immunodeficiency Virus-Positive Subjects. The Journal of Infectious Diseases. 162(3). 643–648. 119 indexed citations
20.
Sculley, T B, et al.. (1989). Expression of Epstein-Barr virus nuclear antigens 3, 4, and 6 are altered in cell lines containing B-type virus. Virology. 171(2). 401–408. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026